Personal information

Verified email domains

Italy

Activities

Employment (3)

GSK Vaccines Institute for Global Health: Siena, IT

2024-08-09 to present | Scientist (Preclinical)
Employment
Source: Self-asserted source
Giacomo Vezzani

GSK Vaccines Institute for Global Health: Siena, Siena, IT

2022-02-01 to 2024-08-08 | Post Doctoral (Preclinical)
Employment
Source: Self-asserted source
Giacomo Vezzani

GSK Vaccines SRL: Siena, Toscana, IT

2018-11-01 to 2022-01-31 | PhD Student (AIMB)
Employment
Source: Self-asserted source
Giacomo Vezzani

Works (5)

Development and Characterization of a 13-Plex Binding Assay to Detect Shigella Antibodies in Human Samples

Open Forum Infectious Diseases
2024-11-27 | Journal article
Contributors: G Vezzani; F Mancini; M M Raso; C Giannelli; R Nappini; G Gasperini; R Rappuoli; F Berlanda Scorza; M Iturriza; F Micoli et al.
Source: check_circle
Crossref

Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa

International Journal of Molecular Sciences
2021-05-06 | Journal article
Contributors: Giada Antonelli; Luigia Cappelli; Paolo Cinelli; Rossella Cuffaro; Benedetta Manca; Sonia Nicchi; Serena Tondi; Giacomo Vezzani; Viola Viviani; Isabel Delany et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Human Cytomegalovirus UL116 Glycoprotein Is a Chaperone to Control gH-Based Complexes Levels on Virions.

Frontiers in microbiology
2021-04-06 | Journal article
Source: Self-asserted source
Giacomo Vezzani

The human cytomegalovirus UL116 glycoprotein is a chaperone to control gH-based complexes levels on virions

2020-11-18 | Preprint
Contributors: Giacomo Vezzani; Diego Amendola; Dong Yu; Sumana Chandramuli; Elisabetta Frigimelica; Domenico Maione; Marcello Merola
Source: check_circle
Crossref

Characterization of pUL5, an HCMV protein interacting with the cellular protein IQGAP1.

Virology
2019-11-03 | Journal article
Source: Self-asserted source
Giacomo Vezzani